Hints and tips:
Related Special Reports
...Adalytics created a list of those hit, which includes dozens of leading brands such as JPMorgan Chase and Johnson & Johnson, as well the US Department of Health & Human Services....
...The manoeuvre helped talks progress despite a dearth of buyout financing due to rising interest rates and growing concerns about the health of broader financial markets....
...Emiliou “is of the view that member states may not request the commission to examine a concentration which does not have a community dimension, even where they have no competence to review such a concentration...
...The US National Football League and Amazon Web Services have developed a player health tool known as the Digital Athlete, which they hope may in time be able to predict and prevent injuries....
...KPMG did not immediately respond to a request for comment....
...Past liability management scenarios presented at JPMorgan’s high-yield and leveraged finance event this week included those of Bausch Health and Dish/EchoStar....
...Menopause has risen up employers’ agenda as acceptance grows that once-private issues, such as mental health, have an impact on working life....
...If nothing else, the notice gives a fair summary of events: On 17 December 2019, Muddy Waters Capital LLC (“Muddy Waters”) published a report which set out a number of detailed allegations impugning the...
...“Injuries are unfortunately a part of the beautiful game, and our player’s health must always come first,” it said....
...At various points over the past 20 years, certain industry groups or companies, whether it be energy or health insurers or something else, have been universally hated and really cheap....
...But the holy grail, says Tamara Rogers, chief marketing officer at consumer health company Haleon, is “right person, right time, right message, right context”. “This is a marketer’s dream,” she adds....
...Software company Palantir has a “strategic commercial contract” with some of the companies it invests in....
...Too many and a market begins to look like a casino and raises suspicions of stock manipulation. But they’re not easy to prevent....
...It uses this to calculate predispositions for ill health while feeding information into a research programme for drug development. So far, however, this vast database has produced little of value....
...Illumina has accused Brussels of putting lives at risk by blocking a deal that aims to bring to market a blood test to screen dozens of different cancers....
...The biggest critique is that it can cross-collateralise a fund’s portfolio and create a drag on performance. It also creates the risk of throwing good money after bad, a cardinal sin....
...One thing to start: Cigna is in talks to merge with Humana in a deal that would create a US health insurance giant worth $140bn and provide a significant test for antitrust authorities, according to people...
...Centerview said it was within its rights to terminate Shiber, claiming that she simply could not meet a basic requirement of a demanding job while the firm also said it worried about the health consequences...
...Plus, disposable vapes aren’t just a growing health concern. They’re also a problem for the environment. Oliver BarnesSay you’re an 18-year-old going out clubbing on a Friday night....
...One sign of a more interventionist approach is revived suspicion of vertical takeovers. These combine businesses throughout a single supply chain....
...Investors clamoured for junk bonds and loans backing private equity groups’ acquisitions of financial technology company Worldpay and healthcare company Syneos Health....
...Read a transcript of this episode on FT.com...
...manufacture GE F-414 jet engines in India....
...The Arm flotation was closely watched as a test of the health of the broader IPO market, and its warm reception — shares jumped 25 per cent on the first day of trading — has bolstered investors’ hopes of...
...The recommendation that shareholders withdraw their support for chief executive Francis deSouza and chair John Thompson is a boost for activist investor Carl Icahn, who has launched a proxy battle against...
International Edition